Case Control Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Feb 16, 2021; 9(5): 1005-1015
Published online Feb 16, 2021. doi: 10.12998/wjcc.v9.i5.1005
Table 1 Baseline study characteristics in elderly patients with vs without metabolic syndrome

Control, n = 102
MS, n = 100
t/χ2
P value
Mean age (years)75.32 ± 7.5576.45 ± 6.900.4430.506
Male, n (%)66 (64.7)67 (67.0)0.1180.731
Educated, n (%)95 (93.1)89 (89.0)1.0650.302
Intelligent working, n (%)90 (88.2)80 (80.0)2.5690.109
Living alone, n (%)10 (9.8)14 (14.0)0.8490.357
Current smoking, n (%) 40 (39.2)47 (47.0)1.2480.264
Alcohol drinking, n (%)14 (13.7)18 (18.0)0.6920.405
Systolic BP (mmHg)121.00 ± 11.29150.30 ± 14.508.0320.005
Diastolic BP (mmHg)71.68 ± 6.8278.57 ± 8.425.3040.022
Waist circumference (cm)82.64 ± 6.8793.44 ± 8.485.5290.020
BMI (kg/m2)22.88 ± 2.7626.39 ± 2.373.5830.060
FPG (mmoL/L)6.09 ± 1.547.73 ± 2.035.5810.019
FINS (mIU/L)10.46 ± 5.3414.46 ± 6.675.1880.024
HOMA-IR2.96 ± 2.025.17 ± 3.4017.449< 0.001
HbA1c (%)3.71 ± 1.534.67 ± 1.915.7490.017
ALT (IU/L)19.98 ± 10.2022.04 ± 11.511.1190.292
ALB (g/L)37.97 ± 4.9838.49 ± 4.280.7210.580
SCr (μmoL/L)80.72 ± 20.3179.94 ± 21.861.3160.253
UA (μmoL/L)327.64 ± 92.27325.86 ± 90.060.0140.907
TG (mmoL/L)1.50 ± 0.742.20 ± 1.104.0690.045
TC (mmoL/L)3.86 ± 0.844.14 ± 1.144.4710.031
LDL-C (mmoL/L)2.10 ± 0.702.60 ± 0.843.6320.058
HDL-C (mmoL/L)1.55 ± 0.521.28 ± 0.38-1.7060.003
HCY (μmoL/L)13.41 ± 4.9013.95 ± 4.541.7430.188
MMSE scale25.93 ± 3.2621.50 ± 4.5111.2680.001
ADL score90.25 ± 14.2082.30 ± 16.064.0380.046
Cognitive dysfunction, n (%)39 (38.2)64 (64.0)13.413< 0.001
ApoEε4 allele, n (%)12 (11.8)21 (21.0)3.1510.076